Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-15

Clinical Trial Update: Efficacy and Safety of Akkermansia Muciniphila AKM Lab-01 for Overweight and Obesity [NA]

View source ↗

Summary

This clinical trial aims to evaluate the efficacy and safety of AKM Lab-01, Akkermansia muciniphila, for overweight and obesity, and it is currently not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AKM Lab-01 (Akkermansia muciniphila)

Snippet

Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd. | Conditions: Overweight , Obesity | NA | Status: NOT_YET_RECRUITING